Altogether, these results indicate that in fibroblasts, A20 negatively regulates fibrotic responses by targeting the activity of distinct pathways (including TGF-ß, Wnt/ß-catenin, FAK, and TRAF6) that are implicated in the pathogenesis of SSc. The gene discussed is TRAF6; the disease is systemic sclerosis.